A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome

BACKGROUND: Decitabine was evaluated for its efficacy and safety in Korean patients with myelodysplastic syndrome with IPSS score of 0.5 or over. DESIGN AND METHODS: Decitabine 20 mg/m(2)/day was given intravenously over one hour for five consecutive days every four weeks. The primary end point was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Je-Hwan, Jang, Jun Ho, Park, Jinny, Park, Seonyang, Joo, Young-Don, Kim, Yeo-Kyeoung, Kim, Hoon-Gu, Choi, Chul Won, Kim, Sung-Hyun, Park, Seong Kyu, Park, Eunkyung, Min, Yoo Hong
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2011
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186304/
https://ncbi.nlm.nih.gov/pubmed/21659363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.046078
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados